Highlights from Eli Lilly CEO’s Bloomberg interview

Eli Lilly And Co (NYSE: LLY) CEO Dave Ricks was interviewed on “Bloomberg Surveillance” Tuesday morning to offer additional commentary on the company’s earlier earnings report and the pharmaceutical giant’s outlook. COVID-19 treatment update Eli Lilly has been working on treatments against the COVID-19 virus that consists of a neutralizing antibody meant for symptomatic individuals in an outpatient setting. According to Ricks’ comments on Bloomberg TV, the company is close to confirming that the treatment of the disease with monoclonal antibodies early in the infection can make a “significant difference” inpatient outcome.  On the other hand, it wasn’t until the